Egypt
Marcyrl Group, a leading global pharmaceutical company, is dedicated to providing innovative and diversified specialty care treatments. With EU GMP certification and Egyptian manufacturing facilities, Marcyrl delivers cost-effective solutions to healthcare practitioners and patients across Africa, GCC, CIS, and LATAM.
Founded in 1996, Marcyrl aims to transform the accessibility of specialty treatments worldwide and ensure high-quality care for those in need. The company recently secured a Private Equity Round investment on 04 April 2023 from Development Partners International (DPI) and Amethis.
Operating within the Biotechnology, Health Care, Manufacturing, and Pharmaceutical industries, Marcyrl's strong presence in key regions underscores its commitment to improving healthcare access on a global scale.
With its focus on driving innovation and accessibility in specialty care, Marcyrl Pharmaceutical Industries presents an attractive investment opportunity in the pharmaceutical sector. The recent injection of capital from reputable investors further solidifies its potential for growth and impact.
